user

Phase I/II trial of bortezimib and pemetrexed in patients with advanced non-small cell lung cancer

被引：0
|
作者：
Natale, R. B.
McKinley, M.
Hilger, J.
Myers, T.
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] Aptium Oncol Res Network, Los Angeles, CA USA
[3] Millennium Pharmaceut Inc, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18145
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Pemetrexed for Heavily Pretreated Patients With Advanced Non-small Cell Lung Cancer
    Lee, Jih-Hsiang
    Yu, Chong-Jen
    Chen, Kuan-Yu
    Shih, Jin-Yuan
    Lin, Yu-Lin
    Yang, Chih-Hsin
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2010, 109 (05) : 338 - 344
  • [32] Pemetrexed for treatment of advanced non-small cell lung cancer
    Fossella, FV
    SEMINARS IN ONCOLOGY, 2004, 31 (01) : 100 - 105
  • [33] Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer
    Yun Fan
    Neng-ming Lin
    Sheng-lin Ma
    Lü-hong Luo
    Luo Fang
    Zhi-yu Huang
    Hai-feng Yu
    Feng-qin Wu
    Acta Pharmacologica Sinica, 2010, 31 : 746 - 752
  • [34] Phase II trial of gefitinib in Chinese female patients with advanced non-small cell lung cancer
    Deng, J.
    Fang, W. J.
    Zhang, X. C.
    Chen, J.
    Qian, J.
    Mou, H. B.
    Xu, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [35] Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer
    Fan, Yun
    Lin, Neng-ming
    Ma, Sheng-lin
    Luo, Lue-hong
    Fang, Luo
    Huang, Zhi-yu
    Yu, Hai-feng
    Wu, Feng-qin
    ACTA PHARMACOLOGICA SINICA, 2010, 31 (06) : 746 - 752
  • [36] PHASE-II TRIAL OF ESORUBICIN IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG-CANCER
    KRIS, MG
    GRALLA, RJ
    BURKE, MT
    FIORE, JJ
    KELSEN, DP
    MARKS, LD
    HEELAN, RT
    CANCER TREATMENT REPORTS, 1987, 71 (7-8): : 783 - 784
  • [37] Phase II Trial of Talabostat and Docetaxel in Advanced Non-small Cell Lung Cancer
    Eager, R. M.
    Cunningham, C. C.
    Senzer, N.
    Richards, D. A.
    Raju, R. N.
    Jones, B.
    Uprichard, M.
    Nemunaitis, J.
    CLINICAL ONCOLOGY, 2009, 21 (06) : 464 - 472
  • [38] Phase II Trial of Gefitinib and Everolimus in Advanced Non-small Cell Lung Cancer
    Price, Katharine A.
    Azzoli, Christopher G.
    Krug, Lee M.
    Pietanza, Maria C.
    Rizvi, Naiyer A.
    Pao, William
    Kris, Mark G.
    Riely, Gregory J.
    Heelan, Robert T.
    Arcila, Maria E.
    Miller, Vincent A.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (10) : 1623 - 1629
  • [39] A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC)
    Kim, Se Hyun
    Shim, Hyo Sup
    Cho, Jaeho
    Jeong, Jae Heon
    Kim, Sun Mi
    Hong, Yun Kyoung
    Sung, Ji Hee
    Ha, Sang-Jun
    Kim, Hye Ryun
    Chang, Hyun
    Kim, Joo Hang
    Tania, Crombet
    Cho, Byoung Chul
    LUNG CANCER, 2013, 79 (03) : 270 - 275
  • [40] A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC).
    Kim, Han Sang
    Cho, Byoung Chul
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345